Arvinas (ARVN) Change in Receivables (2017 - 2026)
Arvinas' (ARVN) quarterly Change in Receivables came in at $800000.0 in Q1 2026, up 115.09% year-on-year from $371929.8 in Q1 2025, and up 104.15% quarter-over-quarter from -$19.3 million in Q4 2025.
Arvinas (ARVN) Change in Receivables (2017 - 2026) Analysis & Trends
Arvinas' Change in Receivables history runs 10 years deep, the most recent figure standing at $800000.0 for Q1 2026.
- On a quarterly basis, Change in Receivables rose 115.09% year-over-year to $800000.0 in Q1 2026; TTM through Mar 2026 was $1.4 million, a 250.0% increase from a year earlier, with the FY2025 full-year figure at -$4.7 million, down 182.46% from the prior year.
- Change in Receivables grew to $800000.0 in Q1 2026 per ARVN's latest filing, from -$19.3 million in the prior quarter.
- Across five years, Change in Receivables topped out at $19.8 million in Q3 2025 and bottomed at -$19.3 million in Q4 2025.
- The 5-year median for Change in Receivables is -$150000.0 (2022), against an average of -$942857.1.
- Across the five-year window, Change in Receivables sank 1400.0% in 2022 and jumped 4000.0% in 2023, its largest moves.
- Year by year, Change in Receivables stood at -$400000.0 in 2022, then tumbled by 3825.0% to -$15.7 million in 2023, then surged by 89.81% to -$1.6 million in 2024, then tumbled by 1106.25% to -$19.3 million in 2025, then jumped by 104.15% to $800000.0 in 2026.
- Per Business Quant, the three latest ARVN Change in Receivables figures stand at $800000.0 (Q1 2026), -$19.3 million (Q4 2025), and $19.8 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - | 800,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 800,000.00 |
| Mar 31, 2026 | 800,000.00 |
| Dec 31, 2025 | -19.30 Mn |
| Dec 31, 2025 | -19.30 Mn |
| Sep 30, 2025 | 19.80 Mn |
| Sep 30, 2025 | 19.80 Mn |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | -5.30 Mn |
| Mar 31, 2025 | -5.30 Mn |
| Dec 31, 2024 | -1.60 Mn |
| Dec 31, 2024 | -1.60 Mn |
| Sep 30, 2024 | 7.30 Mn |
| Sep 30, 2024 | 7.30 Mn |
| Dec 31, 2023 | -15.70 Mn |
| Dec 31, 2023 | -15.70 Mn |
| Sep 30, 2023 | 15.60 Mn |
| Sep 30, 2023 | 15.60 Mn |
| Jun 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |